Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Molecular Point-of-care Xpert® Xpress SARS-CoV-2 Detection Implementation in Resource-limited Settings

NCT05514886 is registered in ClinicalTrials.gov with National Institute for Medical Research, Tanzania as lead sponsor.

NCT NCT05514886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05514886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Molecular Point-of-care Xpert® Xpress SARS-CoV-2 Detection Implementation in Resource-limited Settings
Lead sponsor
National Institute for Medical Research, Tanzania
Phase
Observational
Overall status
Completed
Start date
August 10, 2022
Completion date
February 29, 2024
Enrollment
3,429 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19